NovaBridge Biosciences

(NASDAQ) NBP

Current Price$2.25

Market Cap$274.61M

Since IPO (2020)-81%

5 Year-96%

1 Year+153%

1 Month-7%

NovaBridge Biosciences Financials at a Glance

Market Cap

$274.61M

Revenue (TTM)

$0.00

Net Income (TTM)

$46.27M

EPS (TTM)

$-0.44

P/E Ratio

-5.39

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Price

$2.25

Volume

2,178,601.441

Open

$2.40

Price

$2.25

Volume

2,178,601.441

Open

$2.40

Previous Close

$2.25

Daily Range

$2.25 - $2.45

52-Week Range

$0.83 - $6.79

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Price

$2.25

Volume

2,178,601.441

Open

$2.40

Previous Close

$2.25

Daily Range

$2.25 - $2.45

52-Week Range

$0.83 - $6.79

NBP News

AbbVie Partners With I-Mab for Cancer Drug

Jim CrumlySep 4, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NovaBridge Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Xi-Yong Fu, PhD, MBA

Website

www.i-mabbiopharma.com

Headquarters

Rockville, MD 20850, US

NBP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-40%

Return on Assets

-18%

Earnings Yield

-18.55%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$274.61M

Shares Outstanding

115.38M

Volume

2.18M

Avg. Volume

892.29K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$94.27M

EBITDA

$93.41M

Operating Cash Flow

$20.60M

Capital Expenditure

$7.00K

Free Cash Flow

$20.60M

Cash & ST Invst.

$210.84M

Total Debt

$3.07M

NovaBridge Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$274.61M

N/A

Market Cap/Employee

$8.58M

N/A

Employees

N/A

Net Income

$30.79M

-239.7%

EBITDA

$72.68M

-500.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$207.78M

+22.6%

Accounts Receivable

$1.79M

+53.0%

Inventory

$0.00

N/A

Long Term Debt

$2.18M

-29.0%

Short Term Debt

$891.00K

+9.2%

Return on Assets

-17.76%

N/A

Return on Invested Capital

-40.35%

N/A

Free Cash Flow

$14.60M

N/A

Operating Cash Flow

$14.60M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ALTAltimmune, Inc.

ALTAltimmune, Inc.$3.26+6.54%

DMACDiaMedica Therapeutics Inc.

DMACDiaMedica Therapeutics Inc.$6.52+4.32%

GALTGalectin Therapeutics Inc.

GALTGalectin Therapeutics Inc.$2.25+0.90%

RCKTRocket Pharmaceuticals, Inc.

RCKTRocket Pharmaceuticals, Inc.$3.86+9.04%

ENGNenGene Holdings Inc.

ENGNenGene Holdings Inc.$8.85+12.17%

AURAAura Biosciences, Inc.

AURAAura Biosciences, Inc.$8.29-6.85%

DRTSAlpha Tau Medical Ltd.

DRTSAlpha Tau Medical Ltd.$7.59+2.71%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$113.01+0.04%

NOKNokia

NOKNokia$13.19-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14-0.12%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.58+0.05%

SNAPSnap

SNAPSnap$6.11+0.33%

CTRACoterra Energy

CTRACoterra Energy$32.56-0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.57+0.06%

Questions About NBP

What is the current price of NovaBridge Biosciences?

NovaBridge Biosciences is trading at $2.25 per share.

What is the 52-week range for NovaBridge Biosciences?

Over the past 52 weeks, NovaBridge Biosciences has traded between $0.83 and $6.79.

How much debt does NovaBridge Biosciences have?

As of the most recent reporting period, NovaBridge Biosciences reported total debt of $3.07M.

How much cash does NovaBridge Biosciences have on hand?

NovaBridge Biosciences reported $210.63M in cash and cash equivalents in its most recent financial results.

What is NovaBridge Biosciences’s dividend yield?

NovaBridge Biosciences does not currently have a dividend yield.

NovaBridge Biosciences

NovaBridge Biosciences Financials at a Glance

NBP News

AbbVie Partners With I-Mab for Cancer Drug

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About NovaBridge Biosciences

NBP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

NovaBridge Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NBP

What is the current price of NovaBridge Biosciences?

What is the 52-week range for NovaBridge Biosciences?

How much debt does NovaBridge Biosciences have?

How much cash does NovaBridge Biosciences have on hand?

What is NovaBridge Biosciences’s dividend yield?

Premium Investing Services